Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics

Completed · Phase 2 · Has a placebo group

Conditions studied: Type 2 Diabetes

In brief

Determine the effect of treatment with INCB013739 administered as an 'add-on' to metformin therapy in type 2 diabetic subjects on safety and tolerability and glycemic control.

Key facts

Study ID

NCT00698230

Run by

Incyte Corporation

People needed

302

Starts

2008-05-01

Expected to finish

2009-05-01

Last updated by the study team

2018-02-14

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Established diagnosis of Type 2 Diabetes
• Stable dose of metformin for more than 8 weeks

You may not qualify if…

• Subjects with Addison's disease or Cushing's Syndrome
• Type 1 diabetes mellitus or secondary forms of diabetes
• Subjects with uncontrolled thyroid disease
• History of renal impairment

Where it is running

• Study site — Artesia, California, United States
• Study site — Calabasas, California, United States
• Study site — Fresno, California, United States
• Study site — Los Angeles, California, United States
• Study site — Los Gatos, California, United States
• Study site — Santa Ana, California, United States
• Study site — Colorado Springs, Colorado, United States
• Study site — Chiefland, Florida, United States
• Study site — Hollywood, Florida, United States
• Study site — Longwood, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Miami Beach, Florida, United States
• Study site — Ocala, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — South Miami, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Dunwoody, Georgia, United States
• Study site — Rome, Georgia, United States
• Study site — Belleville, Illinois, United States
• Study site — Shawnee Mission, Kansas, United States
• Study site — Bangor, Maine, United States
• Study site — Columbia, Maryland, United States
• Study site — Sterling Heights, Michigan, United States
• Study site — Florissant, Missouri, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.